114 related articles for article (PubMed ID: 14312669)
1. [APROPOS OF THE USE OF CYCLOPHOSPHAMIDE IN 28 CASES OF MALIGNANT BLOOD DISEASES].
MULLER B
Lyon Med; 1965 Mar; 213():897-916. PubMed ID: 14312669
[No Abstract] [Full Text] [Related]
2. [RESULTS OF THE TREATMENT OF MALIGNANT BLOOD DISEASES WITH RUFOCROMOMYCIN (RP 5278). APROPOS OF 57 CASES].
JACQUILLAT C; BOIRON M; WEILL M; MAZELIER A; BERNARD J
Presse Med (1893); 1965 Jul; 73():2003-6. PubMed ID: 14327353
[No Abstract] [Full Text] [Related]
3. [High-dosed cyclophosphamide therapy of malignant diseases of the lymphoreticulum].
Kühböck J; Pietschmann H
Wien Klin Wochenschr; 1965 Nov; 77(44):883-6. PubMed ID: 5328863
[No Abstract] [Full Text] [Related]
4. [Results of a new trial of prolonged polychemotherapy of inoperable broncho-pulmonary cancers (apropos of 173 cases)].
Decroix G; Sors C; Feldman A; Fournier M
Bull Mem Soc Med Hop Paris; 1968; 119(2):169-78. PubMed ID: 5670365
[No Abstract] [Full Text] [Related]
5. [ON THE PROGNOSIS AND THERAPY OF CHRONIC DISEASES UNDER SPECIAL CONSIDERATION OF BLOOD AND KIDNEY DISEASES].
OEHME J
Med Welt; 1964 May; 21():1173-82. PubMed ID: 14228724
[No Abstract] [Full Text] [Related]
6. [CORTICOSTEROIDS IN HEMATOLOGIC DISEASES].
DIAMOND LK
Rev Med Chil; 1964 Sep; 92():718-24. PubMed ID: 14242630
[No Abstract] [Full Text] [Related]
7. [USE OF GLYCOCORTICOIDS IN SOME BLOOD DISEASES COMPLICATING PREGNANCY].
DIMITROV D
Akush Ginekol (Sofiia); 1964; 3():109-14. PubMed ID: 14244639
[No Abstract] [Full Text] [Related]
8. [Malignant megaloblastoses. Apropos of a case in a child].
FERRAND B; GILLOT F; DESTAING F; DUZER A; ATTALI A
Alger Medicale; 1962 Mar; 66():379-89. PubMed ID: 13892460
[No Abstract] [Full Text] [Related]
9. [Changes in the nucleus of erythroblasts during therapy with cyclophosphamide].
Brichta G; Reimer EE
Wien Z Inn Med; 1966 Apr; 47(4):154-9. PubMed ID: 6005161
[No Abstract] [Full Text] [Related]
10. Long-term efficacy and limitations of cyclophosphamide in myasthenia gravis.
Nagappa M; Netravathi M; Taly AB; Sinha S; Bindu PS; Mahadevan A
J Clin Neurosci; 2014 Nov; 21(11):1909-14. PubMed ID: 25043165
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of single-dose vincristine, actinomycin D, and cyclophosphamide in childhood solid tumors.
Green DM
Cancer Treat Rep; 1978 Oct; 62(10):1517-20. PubMed ID: 709553
[TBL] [Abstract][Full Text] [Related]
12. [ENDOXAN THERAPY IN MALIGNANT PROLIFERATIONS OF THE RETICULOHISTIOCYTIC SYSTEM. (MYCOSIS FUNGOIDES AND RETICULOSARCOMATOSIS)].
KREBS J; LANDES E
Hautarzt; 1965 Feb; 16():76-8. PubMed ID: 14270592
[No Abstract] [Full Text] [Related]
13. [COMPLICATIONS OCCURRING DURING THE TREATMENT OF BLOOD SYSTEM DISEASES WITH CORTICOSTEROID HORMONES].
MITEREV IuG; RUTKOVSKII VV
Probl Gematol Pereliv Krovi; 1965 Jan; 10():20-4. PubMed ID: 14261999
[No Abstract] [Full Text] [Related]
14. [OBSERVATIONS AND RESULTS OF TREATMENT WITH CYCLOPHOSPHAMIDE IN 45 CASES OF LUNG CANCER].
GRASSI F; SCOCCIA S; TANSINI G
G Ital Chemioter; 1964; 11():135-43. PubMed ID: 14279688
[No Abstract] [Full Text] [Related]
15. [THE PLAN OF THERAPY IN CHRONIC BLOOD AND NEOPLASTIC DISEASES].
HITTMAIR A; GABL F; HUBER H; CIRESA M; GOLDBERG K
Med Welt; 1964 Jul; 27():1442-50 PASSIM. PubMed ID: 14250937
[No Abstract] [Full Text] [Related]
16. [Hematologic complications of drug therapy].
Kudrin AN; Zatsepilova TA
Sov Med; 1984; (10):45-8. PubMed ID: 6515448
[No Abstract] [Full Text] [Related]
17. Autoimmune hematologic complications in malignant lymphoproliferative disorders.
Sacks PV
Arch Intern Med; 1974 Oct; 134(4):781-3. PubMed ID: 4606256
[No Abstract] [Full Text] [Related]
18. BLOOD DYSCRASIAS RELATED TO ANTIMICROBIAL AGENTS.
HUGULEY CM
Antimicrob Agents Chemother (Bethesda); 1963; 161():785-92. PubMed ID: 14275004
[No Abstract] [Full Text] [Related]
19. [Cancer of the bladder after cystitis due to cyclophosphamide. Apropos of a case].
Dore B; Grange P; Aubert J
J Urol (Paris); 1989; 95(7):427-31. PubMed ID: 2687398
[TBL] [Abstract][Full Text] [Related]
20. [CEREBRO-MENINGEAL CRYPTOCOCCOSIS AND MALIGNANT BLOOD DISEASES. APROPOS OF 2 OBSERVATIONS].
VIALA JJ; FATH A; RACLE P; MOULINIER B; DESPEIGNES J; CROIZAT P; REVOL L
Lyon Med; 1964 Nov; 212():1059-77. PubMed ID: 14233304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
